Asensus Surgical, Inc. (ASXC) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2021
February 28, 2022 4:05 PM ESTRESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery, today announced its operating and financial results for the fourth quarter and full year 2021.
Fourth Quarter Highlights
Over 500 procedures were performed globally during the quarter, representing growth of 30% over the fourth quarter 2020 Six Senhance Surgical Programs were initiated during the quarter Fourth quarter revenue of $2.5 millionYear-End... More
